BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9593394)

  • 21. HIV seropositivity and related eye diseases in Uith, Ilorin.
    Adepoju FG; Olawumi HO; Adekoya BJ
    Niger Postgrad Med J; 2007 Jun; 14(2):163-5. PubMed ID: 17599118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opportunistic and other intestinal parasitic infections in AIDS patients, HIV seropositive healthy carriers and HIV seronegative individuals in southwest Ethiopia.
    Mariam ZT; Abebe G; Mulu A
    East Afr J Public Health; 2008 Dec; 5(3):169-73. PubMed ID: 19374319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinal pigment epithelial dysfunction in human immunodeficiency virus-infected patients with cytomegalovirus retinitis.
    Harrison JM; van Heuven WA
    Ophthalmology; 1999 Apr; 106(4):790-7. PubMed ID: 10201604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV infection/acquired immunodeficiency syndrome at Siriraj Hospital, 2002: time for secondary prevention.
    Anekthananon T; Ratanasuwan W; Techasathit W; Rongrungruang Y; Suwanagool S
    J Med Assoc Thai; 2004 Feb; 87(2):173-9. PubMed ID: 15061301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical risk factors for cytomegalovirus retinitis in patients with AIDS.
    Hodge WG; Boivin JF; Shapiro SH; Lalonde RG; Shah KC; Murphy BD; Dionne MA; Goela A
    Ophthalmology; 2004 Jul; 111(7):1326-33. PubMed ID: 15234132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of human immunodeficiency virus in ophthalmic surgical patients.
    Ukponmwan CU; Egbagbe EE; Osahon AI
    Niger J Clin Pract; 2009 Jun; 12(2):120-3. PubMed ID: 19764656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of development of tuberculosis in HIV-infected patients.
    Swaminathan S; Ramachandran R; Baskaran G; Paramasivan CN; Ramanathan U; Venkatesan P; Prabhakar R; Datta M
    Int J Tuberc Lung Dis; 2000 Sep; 4(9):839-44. PubMed ID: 10985652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
    Ives NJ; Gazzard BG; Easterbrook PJ
    J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ocular manifestations in patients with human immunodeficiency virus infection before and after the introduction of highly active antiretroviral therapy].
    Mesarić B; Lisić M; Kniewald T; Ugrinović N; Begovac J
    Lijec Vjesn; 2005; 127(5-6):123-8. PubMed ID: 16281473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Herpes simplex virus keratitis among patients who are positive or negative for human immunodeficiency virus: an epidemiologic study.
    Hodge WG; Margolis TP
    Ophthalmology; 1997 Jan; 104(1):120-4. PubMed ID: 9022115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination.
    Sun HY; Ko WC; Tsai JJ; Lee HC; Liu CE; Wong WW; Su SC; Ho MW; Cheng SH; Yang CH; Lin YH; Miao WJ; Sheng WH; Hung CC
    Am J Gastroenterol; 2009 Apr; 104(4):877-84. PubMed ID: 19259078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ocular disorders in patients infected with the human immunodeficiency virus at the University of Benin Teaching Hospital, Benin City, Nigeria.
    Osahon AI; Onunu AN
    Niger J Clin Pract; 2007 Dec; 10(4):283-6. PubMed ID: 18293635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucocutaneous presence of cytomegalovirus associated with human immunodeficiency virus infection: discussion regarding its pathogenetic role.
    Daudén E; Fernández-Buezo G; Fraga J; Cardeñoso L; García-Díez A
    Arch Dermatol; 2001 Apr; 137(4):443-8. PubMed ID: 11295924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective multicentre study of discontinuing prophylaxis for opportunistic infections after effective antiretroviral therapy.
    Green H; Hay P; Dunn DT; McCormack S;
    HIV Med; 2004 Jul; 5(4):278-83. PubMed ID: 15236617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Herpes viruses in periodontal compromised sites: comparison between HIV-positive and -negative patients.
    Grande SR; Imbronito AV; Okuda OS; Lotufo RF; Magalhães MH; Nunes FD
    J Clin Periodontol; 2008 Oct; 35(10):838-45. PubMed ID: 18727655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low CD4+ T-cell count and high HIV viral load precede the development of tuberculosis disease in a cohort of HIV-positive Ethiopians.
    Wolday D; Hailu B; Girma M; Hailu E; Sanders E; Fontanet AL
    Ethiop Med J; 2003 Jun; 41 Suppl 1():67-73. PubMed ID: 15227883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxoplasma gondii antibody in HIV-infected persons.
    Sukthana Y; Chintana T; Lekkla A
    J Med Assoc Thai; 2000 Jun; 83(6):681-4. PubMed ID: 10932497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV infection and AIDS.
    Lloyd A
    P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for cytomegalovirus retinitis in HIV-positive and AIDS patients.
    Sandy CJ; Ferris JD; Bloom PA; Coker RJ; Pinching AJ; Migdal CS
    QJM; 1995 Dec; 88(12):899-903. PubMed ID: 8593550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.